235 related articles for article (PubMed ID: 38474540)
1. Recent Trends in the Synthesis and Bioactivity of Coumarin, Coumarin-Chalcone, and Coumarin-Triazole Molecular Hybrids.
Rohman N; Ardiansah B; Wukirsari T; Judeh Z
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474540
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
Pingaew R; Saekee A; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Oct; 85():65-76. PubMed ID: 25078311
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial, Antiproliferative Effects and Docking Studies of Methoxy Group Enriched Coumarin-Chalcone Hybrids.
Badreddin Musatat A; Kılıçcıoğlu İ; Kurman Y; Dülger G; Alpay M; Yağcı R; Atahan A; Durmuş S
Chem Biodivers; 2023 Mar; 20(3):e202200973. PubMed ID: 36691991
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors.
Kang L; Gao XH; Liu HR; Men X; Wu HN; Cui PW; Oldfield E; Yan JY
Mol Divers; 2018 Nov; 22(4):893-906. PubMed ID: 29934672
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry.
Pereira D; Pinto M; Correia-da-Silva M; Cidade H
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011463
[TBL] [Abstract][Full Text] [Related]
8. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer.
Bhatia R; Rawal RK
Mini Rev Med Chem; 2019; 19(17):1443-1458. PubMed ID: 30854961
[TBL] [Abstract][Full Text] [Related]
9. New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation.
El-Sayed WA; Alminderej FM; Mounier MM; Nossier ES; Saleh SM; F Kassem A
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080455
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Potential of Coumarin and its Derivatives.
Bhattarai N; Kumbhar AA; Pokharel YR; Yadav PN
Mini Rev Med Chem; 2021; 21(19):2996-3029. PubMed ID: 33820507
[TBL] [Abstract][Full Text] [Related]
11. Coumarin-containing hybrids and their anticancer activities.
Zhang L; Xu Z
Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
[TBL] [Abstract][Full Text] [Related]
12. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
G AC; Gondru R; Li Y; Banothu J
Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
[TBL] [Abstract][Full Text] [Related]
13. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
14. Recent Developments of Coumarin-based Hybrids in Drug Discovery.
Xia D; Liu H; Cheng X; Maraswami M; Chen Y; Lv X
Curr Top Med Chem; 2022 Mar; 22(4):269-283. PubMed ID: 34986774
[TBL] [Abstract][Full Text] [Related]
15. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Computational and Pharmacological Evaluation of 7-(2-(2- (3- (Substituted Phenyl) Acryloyl) Phenoxy) Ethoxy)-4-Methyl-2H-Chromen- 2-Ones as CNS Agents.
Kumar S; Kumar A
Cent Nerv Syst Agents Med Chem; 2023; 23(1):57-64. PubMed ID: 36717998
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents.
Sashidhara KV; Kumar A; Kumar M; Sarkar J; Sinha S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7205-11. PubMed ID: 21071221
[TBL] [Abstract][Full Text] [Related]
18. Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.
Singh H; Singh JV; Bhagat K; Gulati HK; Sanduja M; Kumar N; Kinarivala N; Sharma S
Bioorg Med Chem; 2019 Aug; 27(16):3477-3510. PubMed ID: 31255497
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
Wang Y; Zhang W; Dong J; Gao J
Bioorg Chem; 2020 Jan; 95():103530. PubMed ID: 31887477
[TBL] [Abstract][Full Text] [Related]
20. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.
Maurya A; Agrawal A
Mini Rev Med Chem; 2024; 24(2):176-195. PubMed ID: 37497710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
